Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Monday - 7 September 2026

Monday, 7 September 2026

Questions (3290)

James Lawless

Question:

3290. Deputy James Lawless asked the Minister for Health the mechanisms that are currently available to allow patients with progressive pulmonary fibrosis to access a drug (details supplied) on an exceptional or compassionate basis pending completion of the reimbursement process; and if she will consider expanding such arrangements for patients with urgent clinical need. [61110/26]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Question No. 3291 answered with Question No. 3286.
Question No. 3292 answered with Question No. 3286.
Question No. 3293 answered with Question No. 3286.
3294. Reply not received from Department.
Share